Research programme: estrogen-related receptor alpha modulators - Phenex PharmaceuticalsAlternative Names: ERRα modulators - Phenex Pharmaceuticals
Latest Information Update: 22 Sep 2010
At a glance
- Originator Phenex Pharmaceuticals
- Mechanism of Action ERRalpha estrogen-related receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Breast cancer
Most Recent Events
- 22 Sep 2010 Discontinued - Preclinical for Breast cancer in Germany (unspecified route)
- 10 Jul 2008 Preclinical development is ongoing
- 13 Dec 2005 Preclinical trials in Breast cancer in Germany (unspecified route)